Abbott Laboratories (ABT.N) said it would buy Alere Inc (ALR.N) for $5.8 billion to become a leader in point-of-care testing, a fast-growing market as physicians increasingly adopt rapid tests that speed up treatment...
Piramal Abbott Story : Deal Impact
In 2010, Ajay Piramal promoted Piramal Healthcare sold off its main formulation business to Abbott India for over INR 17,000 crore and announced a buy-back of up to 20% of outstanding share capital of the company at INR...
CORONA remedies buys Sanofi India’s ortho brand Myoril
Ahmedabad-based pharmaceutical company CORONA Remedies has acquired leading muscle relaxant brand Myoril from Sanofi India, for Rs234 crore. Corona has acquired Myoril (Thiocolchicoside) and its extensions such as...
KKR Infra fund looks to buy majority stake in supply chain firm Leap India
Private equity firm KKR’s infrastructure fund has started exclusive talks to pick up over 51% stake in supply chain and warehousing asset pooling company Leap India, at an enterprise valuation of around ₹3,000...
Madison Media buys Crow’s Nest
Madison Media has acquired Kolkata-based full-service digital agency, Crow’s Nest which has works with companies like Bandhan Bank, Vivo West Bengal, M P Birla Group among others. After the acquisition, Crow’s Nest will...
Fonterra to sell China JV farms, Beingmate stake as profit jumps 43%
New Zealand’s Fonterra said on Wednesday it will sell its joint venture farms in China and its remaining stake in infant formula maker Beingmate as it looks to move its focus from Beijing and prioritise domestic...
Colombian softgel maker Procaps in talks to go public on Nasdaq – sources
Colombian softgel maker Procaps S.A.S. is in talks to go public on Nasdaq through a merger with U.S. blank-check company Union Acquisition Corp II in a deal which would value it at more than $1 billion, people familiar...
Piramal Pharma readies war chest for potential acquisition targets
After raising Rs 3,523 crore by selling 20 per cent equity to Carlyle Group, Piramal Pharma (PPL) is looking actively for potential acquisition targets, along with growing its existing business. It will list the firm...
Israeli baby formula maker Else to complete share offering this week
Israel’s Else Nutrition, which has developed a plant-based infant formula not made from soy, plans to complete a C$25.7 million ($19.3 million) private placement of its shares this week, its chief executive said...
Piramal Pharma Solutions acquires drug making facility of US-based G&W Laboratories
Piramal Pharma Solutions, which is the contract development and manufacturing company of Piramal Enterprises, has acquired a solid oral dosage drug manufacturing facility of US-based G&W Laboratories for around $17...
Carlyle picks up 20% stake in Piramal pharma biz for $490 mn
Carlyle has agreed to pick up a significant minority stake in Ajay Piramal’s pharma business for $490 million trumping rival private equity peers KKR and TA Associates. The 20% stake sale values Piramal’s pharma...
TPG, KKR in race to buy 20% stake in Piramal pharma biz
American private equity giants TPG Capital and KKR & Co. Inc. have emerged as the front runners to invest ₹3,500-4,000 crore for acquiring a 20% stake in Piramal Group’s proposed pharmaceutical entity that would...